September 8, 2019
Tag: Lung Cancer
July 23, 2019
Woodcock awarded grant to study markers of immunotherapy response in lung cancer
The Lung Cancer Initiative of North Carolina has awarded $25,000 to Mark Woodcock, MD, to support a research effort to identify characteristics of lung cancer patients who will respond to treatments that unlock the immune system against cancer. Woodcock, a fellow in the UNC School of Medicine Division of Hematology/Oncology, was awarded a 2019-20 Lung …
February 4, 2019
System-based intervention reduces racial disparities in treatment for early-stage lung cancer patients
UNC Lineberger's Sam Cykert, MD, and Geni Eng, DrPH, report that a combination of interventions reduced disparities in treatment and outcomes for black patients with early-stage lung cancer.
January 14, 2019
Reuters Health: Lung cancer screening complications may be higher than expected
August 13, 2018
Doctor-patient discussions neglect potential harms of lung cancer screening, study finds
UNC Lineberger researchers led by Daniel Reuland, MD, MPH, report in JAMA Internal Medicine that their analysis of audio-recorded office visit discussions between doctors and patients found the quality of the conversation about lung cancer screening was “poor” and discussion of the potential harms of screening was “virtually nonexistent.”
May 24, 2018
By forming clots in tumors, immune cells aid lung cancer’s spread
Researchers led by UNC Lineberger's Chad Pecot, MD, report in the journal Nature Communications that for a particular subset of lung cancer tumors, there is a high prevalence of immune cells called inflammatory monocytes. These cells, which normally help to build clotting scaffolds to promote wound healing, also make it possible for tumor cells to migrate and spread to other parts of the body.
January 31, 2017
Pecot awarded $400,000 Free to Breathe grant
Funding will support research to evaluate whether targeting inflammatory monocytes through the use of CCR2 inhibitors will blunt or prevent metastasis in squamous cell lung cancer.
July 7, 2015
UNC pulmonology fellow wins grant for lung cancer research
Adam Belanger, MD, a second-year pulmonology fellow in pulmonary diseases and critical care medicine at the UNC School of Medicine, was one of four North Carolina researchers to win a research grant from the Lung Cancer Initiative of North Carolina’s Research Fellows Program.
May 15, 2015
Bobby Kadis: Living life to the fullest
These days Bobby Kadis is living life to the fullest. After being diagnosed with Stage 4 lung cancer, he enrolled in a UNC Lineberger clinical trial using a combination of targeted drug therapies. Now the avid potter, mountain climber and yoga enthusiast celebrates being cancer-free.
May 13, 2015
Bobby Kadis
These days Bobby Kadis is living life to the fullest. After being diagnosed with Stage 4 lung cancer, he enrolled in a UNC Lineberger clinical trial using a combination of targeted drug therapies. Now the avid potter, mountain climber and yoga enthusiast celebrates life to its fullest.